Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,267 | 786 | 99.7% |
| Education | $31.03 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,304 | 105 | $0 (2024) |
| ABBVIE INC. | $1,105 | 85 | $0 (2024) |
| Lilly USA, LLC | $882.29 | 65 | $0 (2024) |
| Amgen Inc. | $697.35 | 52 | $0 (2024) |
| Novo Nordisk Inc | $622.69 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $612.88 | 41 | $0 (2024) |
| PFIZER INC. | $580.50 | 51 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $431.36 | 31 | $0 (2024) |
| Allergan, Inc. | $412.32 | 49 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $401.92 | 33 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,526 | 102 | ABBVIE INC. ($266.59) |
| 2023 | $1,349 | 91 | AbbVie Inc. ($332.52) |
| 2022 | $734.61 | 55 | ABBVIE INC. ($180.49) |
| 2021 | $1,273 | 89 | AbbVie Inc. ($281.01) |
| 2020 | $1,183 | 93 | Allergan, Inc. ($171.21) |
| 2019 | $1,073 | 88 | GlaxoSmithKline, LLC. ($217.88) |
| 2018 | $1,334 | 107 | GlaxoSmithKline, LLC. ($182.94) |
| 2017 | $1,825 | 165 | Lilly USA, LLC ($244.62) |
All Payment Transactions
790 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.92 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: PAIN | ||||||
| 11/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Obesity | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $19.84 | General |
| Category: Medical Device | ||||||
| 09/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,644 | 2,929 | $156,078 | $71,575 |
| 2022 | 25 | 1,600 | 2,586 | $129,362 | $62,648 |
| 2021 | 32 | 1,764 | 2,747 | $141,082 | $46,634 |
| 2020 | 29 | 1,704 | 2,805 | $151,586 | $68,013 |
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 3 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 57 | 77 | $462.00 | $241.06 | 52.2% |
| 83735 | Magnesium level | Office | 2022 | 18 | 23 | $276.00 | $151.80 | 55.0% |
| 84550 | Uric acid level, blood | Office | 2022 | 15 | 15 | $135.00 | $66.84 | 49.5% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2022 | 16 | 18 | $162.00 | $47.81 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 364 | $67,340 | $12,532 | 18.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 106 | 106 | $13,765 | $5,096 | 37.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 136 | 212 | $6,572 | $3,562 | 54.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 138 | 218 | $6,540 | $2,919 | 44.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 146 | 243 | $4,617 | $2,566 | 55.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 38 | 38 | $2,860 | $2,476 | 86.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 146 | 245 | $3,675 | $1,904 | 51.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 51 | $6,375 | $1,824 | 28.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 14 | 28 | $2,380 | $1,735 | 72.9% |
| 82306 | Vitamin d-3 level | Office | 2021 | 39 | 46 | $2,484 | $1,362 | 54.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 68 | 116 | $2,088 | $1,126 | 53.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2021 | 43 | 43 | $1,462 | $830.33 | 56.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 150 | 270 | $2,970 | $810.00 | 27.3% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 21 | 21 | $861.00 | $777.42 | 90.3% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 27 | 130 | $3,770 | $674.23 | 17.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 12 | 13 | $715.00 | $667.03 | 93.3% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 18 | 18 | $738.00 | $666.36 | 90.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 40 | 40 | $1,000 | $629.98 | 63.0% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 17 | 17 | $697.00 | $629.34 | 90.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 12 | 15 | $840.00 | $547.82 | 65.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 29 | 47 | $2,256 | $477.45 | 21.2% |
About Dr. Andrew Becker, D.O
Dr. Andrew Becker, D.O is a Family Medicine healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1700152980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Becker, D.O has received a total of $10,298 in payments from pharmaceutical and medical device companies, with $1,526 received in 2024. These payments were reported across 790 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($10,267).
As a Medicare-enrolled provider, Becker has provided services to 6,712 Medicare beneficiaries, totaling 11,067 services with total Medicare billing of $248,872. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Johnson City, TN
- Active Since 04/01/2012
- Last Updated 02/13/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700152980
Products in Payments
- TRELEGY ELLIPTA (Drug) $698.16
- VRAYLAR (Drug) $593.78
- FARXIGA (Drug) $462.00
- XIFAXAN (Drug) $388.60
- NURTEC ODT (Drug) $370.76
- Aimovig (Biological) $364.16
- TRULICITY (Drug) $338.11
- UBRELVY (Drug) $336.39
- QULIPTA (Drug) $272.11
- TRINTELLIX (Drug) $259.23
- Ozempic (Drug) $251.02
- ANORO (Drug) $241.53
- EMGALITY (Drug) $224.02
- Trintellix (Drug) $207.73
- TRADJENTA (Drug) $192.25
- XARELTO (Drug) $157.38
- MYRBETRIQ (Drug) $153.11
- JARDIANCE (Drug) $148.70
- Livalo (Drug) $123.14
- PRADAXA (Drug) $120.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Johnson City
Leigh Johnson, M.d, M.D
Family Medicine — Payments: $22,383
Dr. Cameron Shawver, D.o, D.O
Family Medicine — Payments: $15,541
Mr. Jeffrey Hopland, M.d, M.D
Family Medicine — Payments: $11,111
Angela Merrifield, Md, MD
Family Medicine — Payments: $10,573
Jane Simpson, Do, DO
Family Medicine — Payments: $10,350
Dr. Jeremy Elliott, Do, DO
Family Medicine — Payments: $9,784